120 related articles for article (PubMed ID: 36740808)
1. Loss of function SMAD4 nonstop mutations in human cancer.
Bauer AH; Basta DW; Hornick JL; Dong F
Histopathology; 2023 Jun; 82(7):1098-1104. PubMed ID: 36740808
[TBL] [Abstract][Full Text] [Related]
2. A pan-cancer analysis reveals nonstop extension mutations causing SMAD4 tumour suppressor degradation.
Dhamija S; Yang CM; Seiler J; Myacheva K; Caudron-Herger M; Wieland A; Abdelkarim M; Sharma Y; Riester M; Groß M; Maurer J; Diederichs S
Nat Cell Biol; 2020 Aug; 22(8):999-1010. PubMed ID: 32719554
[TBL] [Abstract][Full Text] [Related]
3. Loss of SMAD4 protein expression in gastrointestinal and extra-gastrointestinal carcinomas.
Ritterhouse LL; Wu EY; Kim WG; Dillon DA; Hirsch MS; Sholl LM; Agoston AT; Setia N; Lauwers GY; Park DY; Srivastava A; Doyle LA
Histopathology; 2019 Oct; 75(4):546-551. PubMed ID: 31054158
[TBL] [Abstract][Full Text] [Related]
4. Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4.
Hosoda W; Chianchiano P; Griffin JF; Pittman ME; Brosens LA; Noë M; Yu J; Shindo K; Suenaga M; Rezaee N; Yonescu R; Ning Y; Albores-Saavedra J; Yoshizawa N; Harada K; Yoshizawa A; Hanada K; Yonehara S; Shimizu M; Uehara T; Samra JS; Gill AJ; Wolfgang CL; Goggins MG; Hruban RH; Wood LD
J Pathol; 2017 May; 242(1):16-23. PubMed ID: 28188630
[TBL] [Abstract][Full Text] [Related]
5. Colorectal Cancer-Associated Smad4 R361 Hotspot Mutations Boost Wnt/β-Catenin Signaling through Enhanced Smad4-LEF1 Binding.
Lanauze CB; Sehgal P; Hayer K; Torres-Diz M; Pippin JA; Grant SFA; Thomas-Tikhonenko A
Mol Cancer Res; 2021 May; 19(5):823-833. PubMed ID: 33608451
[TBL] [Abstract][Full Text] [Related]
6. The utility of SMAD4 as a diagnostic immunohistochemical marker for pancreatic adenocarcinoma, and its expression in other solid tumors.
Ali S; Cohen C; Little JV; Sequeira JH; Mosunjac MB; Siddiqui MT
Diagn Cytopathol; 2007 Oct; 35(10):644-8. PubMed ID: 17854080
[TBL] [Abstract][Full Text] [Related]
7. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of single base-pair substitutions in translational termination codons ('nonstop' mutations) that cause human inherited disease.
Hamby SE; Thomas NS; Cooper DN; Chuzhanova N
Hum Genomics; 2011 May; 5(4):241-64. PubMed ID: 21712188
[TBL] [Abstract][Full Text] [Related]
9. SMAD4 Y353C promotes the progression of PDAC.
Wang Z; Li Y; Zhan S; Zhang L; Zhang S; Tang Q; Li M; Tan Z; Liu S; Xing X
BMC Cancer; 2019 Nov; 19(1):1037. PubMed ID: 31684910
[TBL] [Abstract][Full Text] [Related]
10. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene.
Bläker H; von Herbay A; Penzel R; Gross S; Otto HF
Oncogene; 2002 Jan; 21(1):158-64. PubMed ID: 11791187
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9.
Ono M; Ono Y; Nakamura T; Tsuchikawa T; Kuraya T; Kuwabara S; Nakanishi Y; Asano T; Matsui A; Tanaka K; Ebihara Y; Kurashima Y; Noji T; Murakami S; Shichinohe T; Mitsuhashi T; Omori Y; Furukawa T; Taniue K; Suzuki M; Sugitani A; Karasaki H; Mizukami Y; Hirano S
Ann Surg Oncol; 2022 Aug; 29(8):5007-5019. PubMed ID: 35399143
[TBL] [Abstract][Full Text] [Related]
12. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
Biankin AV; Biankin SA; Kench JG; Morey AL; Lee CS; Head DR; Eckstein RP; Hugh TB; Henshall SM; Sutherland RL
Gut; 2002 Jun; 50(6):861-8. PubMed ID: 12010891
[TBL] [Abstract][Full Text] [Related]
13. The role of SMAD4 in early-onset colorectal cancer.
Royce SG; Alsop K; Haydon A; Mead L; Smith LD; Tesoriero AA; Giles GG; Jenkins MA; Hopper JL; Southey MC
Colorectal Dis; 2010 Mar; 12(3):213-9. PubMed ID: 19183329
[TBL] [Abstract][Full Text] [Related]
14. Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4.
Masetti M; Acquaviva G; Visani M; Tallini G; Fornelli A; Ragazzi M; Vasuri F; Grifoni D; Di Giacomo S; Fiorino S; Lombardi R; Tuminati D; Ravaioli M; Fabbri C; Bacchi-Reggiani ML; Pession A; Jovine E; de Biase D
Cancer Biomark; 2018 Feb; 21(2):323-334. PubMed ID: 29103024
[TBL] [Abstract][Full Text] [Related]
15. Loss of Smad4 function in pancreatic tumors: C-terminal truncation leads to decreased stability.
Maurice D; Pierreux CE; Howell M; Wilentz RE; Owen MJ; Hill CS
J Biol Chem; 2001 Nov; 276(46):43175-81. PubMed ID: 11553622
[TBL] [Abstract][Full Text] [Related]
16. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH
BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091
[TBL] [Abstract][Full Text] [Related]
17. A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumours.
Lazzereschi D; Nardi F; Turco A; Ottini L; D'Amico C; Mariani-Costantini R; Gulino A; Coppa A
Oncogene; 2005 Aug; 24(34):5344-54. PubMed ID: 15940269
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
19. SMAD4 genetic alterations predict a worse prognosis in patients with pancreatic ductal adenocarcinoma.
Singh P; Srinivasan R; Wig JD
Pancreas; 2012 May; 41(4):541-6. PubMed ID: 22504380
[TBL] [Abstract][Full Text] [Related]
20. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.
Hofving T; Elias E; Rehammar A; Inge L; Altiparmak G; Persson M; Kristiansson E; Johansson ME; Nilsson O; Arvidsson Y
BMC Cancer; 2021 Jan; 21(1):101. PubMed ID: 33509126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
